1) Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O'Donnell C, Kittner S, Lloyd-Jones D, Goff DC Jr, Hong Y, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wasserthiel-Smoller S, Wilson M, Wolf P : Heart disease and stroke statistics-2006 update : a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006 ; 113 (6) : e85-151.
3) Turnbull F : Effects of different blood-pressure-lowering regimens on major cardiovascular events : results of prospectively-designed overviews of randomised trials. Lancet. 2003 ; 362 (9395) : 1527-1535.
4) Blood Pressure Lowering Treatment Trialists' Collaboration, Turnbull F, Neal B, Pfeffer M, Kostis J, Algert C, Woodward M, et al. : Blood pressuredependent and independent effects of agents that inhibit the reninangiotensin system. J Hypertens. 2007 ; 25 (5) : 951-958.
6) 日本高血圧学会高血圧治療ガイドライン作成委員会編 : 高血圧治療ガイドライン 2019. 日本高血圧学会, 2019.
7) Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, et al. : Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine : the VALUE randomized trial. Lancet. 2004 ; 363 (9426) : 2022-2031.
9) NHS Employers Quality and Outcomes Framework guidance for GMS contract 2011/12 Delivering investment in general practice April 2011. http://www.nhsemployers.org/Aboutus/Publications/Documents/QOF_guidance_GMS_contract_2011_12.pdf (2014. 06. 24 available)
10) Phillips LS, Branch WT, Cook CB, et al. : Clinical inertia. Ann Intern Med. 2001 ; 135 (9) : 825-834.